Alibaba Health Information Technology Limited
ALBHFOTCHealthcare● Active
$0.42
$-0.04(-9.74%)
Market Cap$6.7B
P/E Ratio—
52W High$0.9
52W Low$0.4152
Alibaba Health Information Technology Limited (ALBHF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALBHF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
$0.01
Est. $0.01 · -18.6%
Revenue
$2.49B
Est. $2.67B · -6.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
ALBHF reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.00
Rev. $1.80B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.00
Rev. Est.$1.80B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2026 | Dec 1, 2026 | $0.01 | — | — | — | $2.71B | — |
| ▼ Q2 FY2026 | May 14, 2026 | $0.01 | $0.01 | -18.6% | $2.49B | $2.67B | -6.8% |
| ▼ Q2 FY2025 | May 19, 2025 | $0.01 | $0.01 | -41.6% | $2.24B | $2.18B | +3.1% |
| ▼ Q4 FY2024 | Nov 13, 2024 | $0.01 | $0.01 | -20.4% | $2.03B | $2.13B | -4.3% |
| ◌ Q3 FY2024 | Aug 9, 2024 | — | — | — | — | — | — |
| ▼ Q2 FY2024 | May 27, 2024 | $0.01 | $0.00 | -40.2% | $1.95B | $1.72B | +13.3% |
| ◌ Q1 FY2024 | Jan 16, 2024 | — | — | — | — | — | — |
| ▲ Q3 FY2023 | Sep 30, 2023 | $0.00 | $0.00 | +228.5% | $1.77B | $1.76B | +0.5% |
Q4 FY2026
Dec 1, 2026
EPS Actual
—
EPS Est.
$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
-18.6%
Revenue
$2.49B
Q2 FY2025
May 19, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
-41.6%
Revenue
$2.24B
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
-20.4%
Revenue
$2.03B
Q3 FY2024
Aug 9, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 27, 2024Miss
EPS Actual
$0.00
EPS Est.
$0.01
EPS Surpr.
-40.2%
Revenue
$1.95B
Q1 FY2024
Jan 16, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Sep 30, 2023Beat
EPS Actual
$0.00
EPS Est.
$0.00
EPS Surpr.
+228.5%
Revenue
$1.77B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.08 | $0.08 | $0.08 | 1 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2024 | $0.06 | $0.06 | $0.06 | 1 |
| Q1 FY2024 | $0.01 | $0.01 | $0.01 | 1 |
| Q3 FY2023 | $0.01 | $0.01 | $0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $117B | $117B | $117B | 1 |
| Q2 FY2025 | $17.1B | $17.1B | $17.1B | 1 |
| Q3 FY2024 | $105B | $105B | $105B | 1 |
| Q1 FY2024 | $89.7B | $89.7B | $89.7B | 1 |
| Q3 FY2023 | $94.0B | $94.0B | $94.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -18.6% | $0.57 | $0.57 | +0.00% |
| ▼ Q2 FY2025 | May 19, 2025 | -41.6% | $0.68 | $0.67 | -0.74% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -20.4% | $0.55 | $0.55 | +0.00% |
| ▼ Q2 FY2024 | May 27, 2024 | -40.2% | $0.39 | $0.42 | +8.02% |
| ▲ Q3 FY2023 | Sep 30, 2023 | +228.5% | $0.61 | $0.60 | -0.24% |
| ▼ Q1 FY2023 | Mar 31, 2023 | -8.5% | $0.78 | $0.74 | -5.87% |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.46 | $0.45 | -2.17% |
| ▲ Q1 FY2022 | Mar 31, 2022 | +83.5% | $0.65 | $0.65 | -0.73% |
Q2 FY2026+0.00%
Report Date
May 14, 2026
EPS Beat/Miss
-18.6%
Price Before
$0.57
Price After
$0.57
Q2 FY2025-0.74%
Report Date
May 19, 2025
EPS Beat/Miss
-41.6%
Price Before
$0.68
Price After
$0.67
Q4 FY2024+0.00%
Report Date
Nov 13, 2024
EPS Beat/Miss
-20.4%
Price Before
$0.55
Price After
$0.55
Q2 FY2024+8.02%
Report Date
May 27, 2024
EPS Beat/Miss
-40.2%
Price Before
$0.39
Price After
$0.42
Q3 FY2023-0.24%
Report Date
Sep 30, 2023
EPS Beat/Miss
+228.5%
Price Before
$0.61
Price After
$0.60
Q1 FY2023-5.87%
Report Date
Mar 31, 2023
EPS Beat/Miss
-8.5%
Price Before
$0.78
Price After
$0.74
Q3 FY2022-2.17%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$0.46
Price After
$0.45
Q1 FY2022-0.73%
Report Date
Mar 31, 2022
EPS Beat/Miss
+83.5%
Price Before
$0.65
Price After
$0.65
Avg Beat Reaction-0.48%
Avg Miss Reaction+0.28%
Beat Rate2 / 8 quarters
Largest Move+8.02% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALBHF ends December
Alibaba Health Information Technology Limited (ALBHF) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $0.01 — missing the analyst consensus of $0.01 by -18.6%. The next ALBHF earnings date is expected around September 1, 2026.
Each quarter, investors track ALBHF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALBHF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALBHF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALBHF earnings · 5 questionsAlibaba Health Information Technology Limited's next earnings report is expected around September 1, 2026. ALBHF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALBHF historically reports after market close (AMC).
ALBHF earnings datewhen is ALBHF earningsALBHF next earnings datewhen does ALBHF report earningsALBHF earnings calendar
▸ Source: FMP · Alibaba Health Information Technology Limited SEC filings · US GAAP · Alibaba Health Information Technology Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026